Nguyen HV, Li AS, Silva AR, Leng T, et al. Ocular adverse events following intravitreal brolucizumab for neovascular age-related macular degeneration at a single tertiary care center. Eur J Ophthalmol 2021 Nov 11:11206721211059332. doi: 10.1177/11206721211059332.
PMID: 34761684